{"gene":"GNAT1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":2007,"finding":"The GNAT1 p.Gly38Asp mutation produces an α-transducin that is unable to activate its downstream effector molecule in vitro, while the novel p.Gln200Glu substitution in the Switch 2 region (GTPase active site) is predicted and supported by trypsin protection assays to impair GTPase activity, leading to constitutive activation of phototransduction.","method":"In vitro expression assay, trypsin protection assay, computer modeling based on crystal structure of transducin","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 1/2 — in vitro functional assay and structural modeling with trypsin protection assay, single study","pmids":["17584859"],"is_preprint":false},{"year":2009,"finding":"A nonsense mutation (Tyr150Ter) caused by a 57-bp intronic deletion disrupting the splice donor site of intron 4 in Gnat1 results in absence of the rod transducin α-subunit protein and consequent rod dysfunction in spontaneous mouse models (IRD1/IRD2).","method":"Quantitative RT-PCR, immunohistochemistry, western blot, sequencing of cDNA and genomic DNA","journal":"Experimental eye research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (RT-PCR, IHC, western blot, sequencing) in a single study establishing loss-of-function mechanism","pmids":["19766629"],"is_preprint":false},{"year":2012,"finding":"A homozygous missense mutation p.D129G in GNAT1 segregates with autosomal recessive congenital stationary night blindness, and GNAT1 is predominantly expressed in the retina starting from approximately postnatal day 7.","method":"Genome-wide linkage analysis, bidirectional sequencing, quantitative expression analysis in ocular tissues","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 — genetic and expression evidence linking specific mutation to loss of rod phototransduction function, single study","pmids":["22190596"],"is_preprint":false},{"year":2015,"finding":"A homozygous truncating mutation in GNAT1 causing complete loss of transducin function leads to both lifelong night blindness and late-onset retinitis pigmentosa/retinal degeneration, demonstrating that GNAT1 loss-of-function can cause progressive rod-cone dystrophy in addition to stationary night blindness.","method":"Targeted gene panel sequencing (182 retinopathy genes), clinical phenotyping including ERG and fundus examination","journal":"The British journal of ophthalmology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic loss-of-function with specific clinical/ERG phenotype, consistent with Gnat1 knockout mouse, single study","pmids":["26472407"],"is_preprint":false},{"year":2018,"finding":"A novel GNAT1 missense variant (c.155T>A, p.Ile52Asn) affecting the first α-helix and a predicted nuclear localization signal (but not the GTP-binding site) causes autosomal dominant Riggs-type CSNB; subcellular protein localization of this and other GNAT1 CSNB mutants is unaltered in mammalian overexpressing cells, suggesting a mechanism distinct from mislocalization.","method":"Mutation cosegregation analysis, domain prediction, 3D structural modeling, subcellular localization in mammalian cells","journal":"BioMed research international","confidence":"Low","confidence_rationale":"Tier 3 — localization assay in overexpressing cells without functional rescue; structural modeling is computational","pmids":["29850563"],"is_preprint":false},{"year":2022,"finding":"Gnat1−/−; Gnat2cpfl3/cpfl3 double-knockout mice, which completely lack rod and cone α-transducin and thus abolish rod and cone photoresponses, still exhibit robust visually evoked potentials with delayed kinetics, demonstrating that melanopsin-expressing ipRGCs can mediate pattern-forming visual signals independently of rod/cone phototransduction.","method":"Visual evoked potential (VEP) recording and electroretinogram (ERG) in genetic knockout mice","journal":"Frontiers in cellular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — clean genetic knockout with defined electrophysiological phenotype, functional consequence clearly tied to loss of GNAT1/GNAT2","pmids":["36605613"],"is_preprint":false},{"year":2025,"finding":"In Gnat1-deficient (rod-deficient, cone-only) mouse retinas, sildenafil (PDE6 inhibitor) completely abolished visually evoked responses, whereas Gnat2-deficient (cone-deficient, rod-only) retinas retained responses, demonstrating that sildenafil preferentially inhibits cone PDE6 and that cone phototransduction mediated via GNAT1-independent pathway is required for Off-pathway RGC signaling.","method":"Ex vivo multi-electrode array recording in Gnat1 and Gnat2 knockout mouse retinas treated with sildenafil","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — clean genetic knockout model with pharmacological perturbation and electrophysiological readout, preprint not yet peer-reviewed","pmids":["bio_10.1101_2025.10.07.680926"],"is_preprint":true}],"current_model":"GNAT1 encodes the α-subunit of rod transducin, a key G-protein in the rod phototransduction cascade; it is activated upon rhodopsin stimulation, amplifies the light signal by activating downstream effectors (including cGMP phosphodiesterase), and terminates signaling via intrinsic GTPase activity in the Switch 2 domain — loss-of-function mutations cause stationary night blindness or progressive rod-cone dystrophy, while constitutively activating GTPase-impaired mutants (e.g., p.Gln200Glu) also cause dominant night blindness by locking the cascade in an active state."},"narrative":{"teleology":[{"year":2007,"claim":"Defined how specific GNAT1 mutations differentially disrupt transducin function: p.Gly38Asp abolishes effector activation while p.Gln200Glu in the Switch 2 GTPase active site impairs GTP hydrolysis, establishing that both loss-of-function and constitutive-activation mechanisms can underlie night blindness.","evidence":"In vitro expression assays, trypsin protection assays, and crystal-structure-based modeling of recombinant α-transducin variants","pmids":["17584859"],"confidence":"Medium","gaps":["GTPase impairment of p.Gln200Glu inferred from trypsin protection and modeling rather than direct GTP hydrolysis rate measurement","No in vivo electrophysiological confirmation of constitutive activation","Structural consequences not validated by direct crystallography of the mutant"]},{"year":2009,"claim":"Demonstrated that complete loss of rod α-transducin protein, caused by a nonsense mutation from an intronic deletion disrupting splicing, produces rod dysfunction, establishing that GNAT1 is essential for rod photoreceptor signaling in vivo.","evidence":"Western blot, immunohistochemistry, quantitative RT-PCR, and genomic/cDNA sequencing in spontaneous IRD1/IRD2 mouse models","pmids":["19766629"],"confidence":"High","gaps":["Whether rod photoreceptors degenerate progressively in this model was not assessed longitudinally","Mechanism by which absence of α-transducin affects photoreceptor survival versus function not separated"]},{"year":2012,"claim":"Linked a specific homozygous missense mutation (p.D129G) to autosomal recessive congenital stationary night blindness in humans and established that GNAT1 retinal expression initiates around postnatal day 7, defining its developmental onset.","evidence":"Genome-wide linkage analysis, bidirectional sequencing, and quantitative expression profiling in ocular tissues","pmids":["22190596"],"confidence":"Medium","gaps":["Functional impact of p.D129G on GTP binding or effector activation not directly assayed","Expression timing studied in mouse; human developmental onset not confirmed"]},{"year":2015,"claim":"Expanded the clinical spectrum by showing that a homozygous GNAT1 truncating mutation causes not only stationary night blindness but also late-onset progressive rod-cone dystrophy, establishing that complete loss of transducin can lead to photoreceptor degeneration.","evidence":"Targeted gene panel sequencing of 182 retinopathy genes with clinical phenotyping including ERG and fundoscopy","pmids":["26472407"],"confidence":"Medium","gaps":["Molecular mechanism linking absence of transducin to progressive photoreceptor degeneration unknown","Single family; broader genotype-phenotype correlation for progressive disease not established"]},{"year":2018,"claim":"Identified a novel dominant GNAT1 missense variant (p.Ile52Asn) in the first α-helix and showed that CSNB-associated mutants do not mislocalize, ruling out gross subcellular redistribution as a dominant disease mechanism.","evidence":"Cosegregation analysis, 3D structural modeling, and subcellular localization of overexpressed mutants in mammalian cells","pmids":["29850563"],"confidence":"Low","gaps":["Localization assay was in overexpressing non-photoreceptor cells without functional rescue—relevance to rod outer segments uncertain","Dominant-negative versus gain-of-function mechanism not distinguished biochemically","No assessment of interaction with rhodopsin or Gβγ subunits"]},{"year":2022,"claim":"Using Gnat1/Gnat2 double-knockout mice, demonstrated that complete elimination of rod and cone transducin abolishes classical phototransduction but melanopsin-driven intrinsically photosensitive RGCs can still mediate pattern-forming vision, placing GNAT1 loss in the context of residual non-rod/cone visual function.","evidence":"Visual evoked potential and ERG recordings in Gnat1−/−;Gnat2cpfl3/cpfl3 double-knockout mice","pmids":["36605613"],"confidence":"Medium","gaps":["Whether melanopsin-mediated vision compensates behaviorally in GNAT1-deficient humans not tested","Temporal and contrast sensitivity limits of the residual pathway not fully characterized"]},{"year":null,"claim":"The precise structural and biochemical basis of dominant GNAT1 mutations (e.g., how p.Ile52Asn or p.Gln200Glu disrupt the transducin cycle at atomic resolution) and the mechanism by which complete transducin loss leads to progressive photoreceptor degeneration remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No high-resolution structure of disease-associated GNAT1 mutants","Molecular pathway from transducin absence to rod-cone degeneration not identified","No gene therapy or rescue experiments reported for GNAT1 deficiency"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[0]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1,5]}],"localization":[],"pathway":[{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[0,1,2,5]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1]}],"complexes":["rod transducin heterotrimer"],"partners":["PDE6"],"other_free_text":[]},"mechanistic_narrative":"GNAT1 encodes the α-subunit of rod transducin, a heterotrimeric G-protein that couples light-activated rhodopsin to downstream phototransduction effectors in retinal rod photoreceptors. Upon photon absorption by rhodopsin, GNAT1 exchanges GDP for GTP and activates cGMP phosphodiesterase (PDE6), amplifying the visual signal; signal termination depends on intrinsic GTPase activity localized to the Switch 2 domain, and mutations impairing this activity (e.g., p.Gln200Glu) lock the cascade in a constitutively active state [PMID:17584859]. Loss-of-function mutations—including missense (p.Gly38Asp, p.Asp129Gly), truncating, and splice-disrupting variants—abolish rod-mediated signaling, causing autosomal recessive congenital stationary night blindness and, in some cases, progressive rod-cone dystrophy [PMID:19766629, PMID:22190596, PMID:26472407]. Dominant gain-of-function or dominant-negative missense variants (p.Gln200Glu, p.Ile52Asn) cause autosomal dominant Riggs-type congenital stationary night blindness through mechanisms that do not involve gross protein mislocalization [PMID:17584859, PMID:29850563]."},"prefetch_data":{"uniprot":{"accession":"P11488","full_name":"Guanine nucleotide-binding protein G(t) subunit alpha-1","aliases":["Transducin alpha-1 chain"],"length_aa":350,"mass_kda":40.0,"function":"Functions as a signal transducer for the rod photoreceptor RHO. Required for normal RHO-mediated light perception by the retina (PubMed:22190596). Guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs), such as the photoreceptor RHO. The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state. Activated RHO promotes GDP release and GTP binding. Signaling is mediated via downstream effector proteins, such as cGMP-phosphodiesterase (By similarity)","subcellular_location":"Cell projection, cilium, photoreceptor outer segment; Membrane; Photoreceptor inner segment","url":"https://www.uniprot.org/uniprotkb/P11488/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GNAT1","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GNAT1","total_profiled":1310},"omim":[{"mim_id":"619926","title":"KELCH-LIKE FAMILY, MEMBER 18; KLHL18","url":"https://www.omim.org/entry/619926"},{"mim_id":"616389","title":"NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G; CSNB1G","url":"https://www.omim.org/entry/616389"},{"mim_id":"610445","title":"NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1; CSNBAD1","url":"https://www.omim.org/entry/610445"},{"mim_id":"610444","title":"NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3","url":"https://www.omim.org/entry/610444"},{"mim_id":"604863","title":"LECITHIN RETINOL ACYLTRANSFERASE; LRAT","url":"https://www.omim.org/entry/604863"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mid piece","reliability":"Approved"},{"location":"Principal piece","reliability":"Approved"},{"location":"End piece","reliability":"Approved"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"retina","ntpm":1040.7}],"url":"https://www.proteinatlas.org/search/GNAT1"},"hgnc":{"alias_symbol":["CSNBAD3"],"prev_symbol":[]},"alphafold":{"accession":"P11488","domains":[{"cath_id":"3.40.50.300","chopping":"35-56_194-335","consensus_level":"high","plddt":96.3809,"start":35,"end":335},{"cath_id":"1.10.400.10","chopping":"58-164","consensus_level":"high","plddt":97.0427,"start":58,"end":164}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P11488","model_url":"https://alphafold.ebi.ac.uk/files/AF-P11488-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P11488-F1-predicted_aligned_error_v6.png","plddt_mean":94.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GNAT1","jax_strain_url":"https://www.jax.org/strain/search?query=GNAT1"},"sequence":{"accession":"P11488","fasta_url":"https://rest.uniprot.org/uniprotkb/P11488.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P11488/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P11488"}},"corpus_meta":[{"pmid":"22190596","id":"PMC_22190596","title":"GNAT1 associated with autosomal recessive congenital stationary night blindness.","date":"2012","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/22190596","citation_count":66,"is_preprint":false},{"pmid":"27912775","id":"PMC_27912775","title":"A novel long non-coding RNA lnc-GNAT1-1 is low expressed in colorectal cancer and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit.","date":"2016","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/27912775","citation_count":56,"is_preprint":false},{"pmid":"26472407","id":"PMC_26472407","title":"A novel homozygous truncating GNAT1 mutation implicated in retinal degeneration.","date":"2015","source":"The British journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/26472407","citation_count":36,"is_preprint":false},{"pmid":"17584859","id":"PMC_17584859","title":"p.Gln200Glu, a putative constitutively active mutant of rod alpha-transducin (GNAT1) in autosomal dominant congenital stationary night blindness.","date":"2007","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17584859","citation_count":36,"is_preprint":false},{"pmid":"30132541","id":"PMC_30132541","title":"Long non‑coding RNA lnc‑GNAT1‑1 inhibits gastric cancer cell proliferation and invasion through the Wnt/β‑catenin pathway in Helicobacter pylori infection.","date":"2018","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/30132541","citation_count":21,"is_preprint":false},{"pmid":"31583501","id":"PMC_31583501","title":"Coexistence of GNAT1 and ABCA4 variants associated with Nougaret-type congenital stationary night blindness and childhood-onset cone-rod dystrophy.","date":"2019","source":"Documenta ophthalmologica. Advances in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/31583501","citation_count":18,"is_preprint":false},{"pmid":"27977773","id":"PMC_27977773","title":"Identification of a Novel Homozygous Nonsense Mutation Confirms the Implication of GNAT1 in Rod-Cone Dystrophy.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27977773","citation_count":18,"is_preprint":false},{"pmid":"30051303","id":"PMC_30051303","title":"Riggs-type dominant congenital stationary night blindness: ERG findings, a new GNAT1 mutation and a systemic association.","date":"2018","source":"Documenta ophthalmologica. Advances in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/30051303","citation_count":13,"is_preprint":false},{"pmid":"19766629","id":"PMC_19766629","title":"A nonsense mutation in Gnat1, encoding the alpha subunit of rod transducin, in spontaneous mouse models of retinal dysfunction.","date":"2009","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/19766629","citation_count":12,"is_preprint":false},{"pmid":"29850563","id":"PMC_29850563","title":"A Novel Heterozygous Missense Mutation in GNAT1 Leads to Autosomal Dominant Riggs Type of Congenital Stationary Night Blindness.","date":"2018","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/29850563","citation_count":11,"is_preprint":false},{"pmid":"33193591","id":"PMC_33193591","title":"Long Non-coding RNA lnc-GNAT1-1 Suppresses Liver Cancer Progression via Modulation of Epithelial-Mesenchymal Transition.","date":"2020","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33193591","citation_count":7,"is_preprint":false},{"pmid":"39349166","id":"PMC_39349166","title":"The Plastidial Protein Acetyltransferase GNAT1 Forms a Complex With GNAT2, yet Their Interaction Is Dispensable for State Transitions.","date":"2024","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/39349166","citation_count":6,"is_preprint":false},{"pmid":"17222360","id":"PMC_17222360","title":"[Expression, loss of heterozygosity, and methylation of GNAT1 gene in nasopharyngeal carcinoma].","date":"2007","source":"Ai zheng = Aizheng = Chinese journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17222360","citation_count":6,"is_preprint":false},{"pmid":"36605613","id":"PMC_36605613","title":"Robust visual cortex evoked potentials (VEP) in Gnat1 and Gnat2 knockout mice.","date":"2022","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/36605613","citation_count":4,"is_preprint":false},{"pmid":"35132885","id":"PMC_35132885","title":"Sleep Deprivation Does not Change the Flash Electroretinogram in Wild-type and Opn4 Mice.","date":"2022","source":"Journal of biological rhythms","url":"https://pubmed.ncbi.nlm.nih.gov/35132885","citation_count":3,"is_preprint":false},{"pmid":"31696758","id":"PMC_31696758","title":"Novel homozygous in-frame deletion of GNAT1 gene causes golden appearance of fundus and reduced scotopic ERGs similar to that in Oguchi disease in Japanese family.","date":"2019","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31696758","citation_count":2,"is_preprint":false},{"pmid":"41954843","id":"PMC_41954843","title":"Autosomal dominant Riggs-type congenital stationary night blindness with fundus sheen and retinal atrophy due to a novel GNAT1 p.Gln200Arg variant.","date":"2026","source":"Documenta ophthalmologica. Advances in ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/41954843","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.07.680926","title":"Sildenafil-driven cone PDE6 inhibition alters receptive-field properties of retinal ganglion cells ex vivo","date":"2025-10-07","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.07.680926","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.05.14.594181","title":"Melanopsin ganglion cells in the mouse retina independently evoke pupillary light reflex","date":"2024-05-14","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.14.594181","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11804,"output_tokens":1755,"usd":0.030869},"stage2":{"model":"claude-opus-4-6","input_tokens":5038,"output_tokens":2001,"usd":0.112823},"total_usd":0.143692,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"The GNAT1 p.Gly38Asp mutation produces an α-transducin that is unable to activate its downstream effector molecule in vitro, while the novel p.Gln200Glu substitution in the Switch 2 region (GTPase active site) is predicted and supported by trypsin protection assays to impair GTPase activity, leading to constitutive activation of phototransduction.\",\n      \"method\": \"In vitro expression assay, trypsin protection assay, computer modeling based on crystal structure of transducin\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1/2 — in vitro functional assay and structural modeling with trypsin protection assay, single study\",\n      \"pmids\": [\"17584859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"A nonsense mutation (Tyr150Ter) caused by a 57-bp intronic deletion disrupting the splice donor site of intron 4 in Gnat1 results in absence of the rod transducin α-subunit protein and consequent rod dysfunction in spontaneous mouse models (IRD1/IRD2).\",\n      \"method\": \"Quantitative RT-PCR, immunohistochemistry, western blot, sequencing of cDNA and genomic DNA\",\n      \"journal\": \"Experimental eye research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (RT-PCR, IHC, western blot, sequencing) in a single study establishing loss-of-function mechanism\",\n      \"pmids\": [\"19766629\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A homozygous missense mutation p.D129G in GNAT1 segregates with autosomal recessive congenital stationary night blindness, and GNAT1 is predominantly expressed in the retina starting from approximately postnatal day 7.\",\n      \"method\": \"Genome-wide linkage analysis, bidirectional sequencing, quantitative expression analysis in ocular tissues\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and expression evidence linking specific mutation to loss of rod phototransduction function, single study\",\n      \"pmids\": [\"22190596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A homozygous truncating mutation in GNAT1 causing complete loss of transducin function leads to both lifelong night blindness and late-onset retinitis pigmentosa/retinal degeneration, demonstrating that GNAT1 loss-of-function can cause progressive rod-cone dystrophy in addition to stationary night blindness.\",\n      \"method\": \"Targeted gene panel sequencing (182 retinopathy genes), clinical phenotyping including ERG and fundus examination\",\n      \"journal\": \"The British journal of ophthalmology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with specific clinical/ERG phenotype, consistent with Gnat1 knockout mouse, single study\",\n      \"pmids\": [\"26472407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A novel GNAT1 missense variant (c.155T>A, p.Ile52Asn) affecting the first α-helix and a predicted nuclear localization signal (but not the GTP-binding site) causes autosomal dominant Riggs-type CSNB; subcellular protein localization of this and other GNAT1 CSNB mutants is unaltered in mammalian overexpressing cells, suggesting a mechanism distinct from mislocalization.\",\n      \"method\": \"Mutation cosegregation analysis, domain prediction, 3D structural modeling, subcellular localization in mammalian cells\",\n      \"journal\": \"BioMed research international\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — localization assay in overexpressing cells without functional rescue; structural modeling is computational\",\n      \"pmids\": [\"29850563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Gnat1−/−; Gnat2cpfl3/cpfl3 double-knockout mice, which completely lack rod and cone α-transducin and thus abolish rod and cone photoresponses, still exhibit robust visually evoked potentials with delayed kinetics, demonstrating that melanopsin-expressing ipRGCs can mediate pattern-forming visual signals independently of rod/cone phototransduction.\",\n      \"method\": \"Visual evoked potential (VEP) recording and electroretinogram (ERG) in genetic knockout mice\",\n      \"journal\": \"Frontiers in cellular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic knockout with defined electrophysiological phenotype, functional consequence clearly tied to loss of GNAT1/GNAT2\",\n      \"pmids\": [\"36605613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In Gnat1-deficient (rod-deficient, cone-only) mouse retinas, sildenafil (PDE6 inhibitor) completely abolished visually evoked responses, whereas Gnat2-deficient (cone-deficient, rod-only) retinas retained responses, demonstrating that sildenafil preferentially inhibits cone PDE6 and that cone phototransduction mediated via GNAT1-independent pathway is required for Off-pathway RGC signaling.\",\n      \"method\": \"Ex vivo multi-electrode array recording in Gnat1 and Gnat2 knockout mouse retinas treated with sildenafil\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic knockout model with pharmacological perturbation and electrophysiological readout, preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.10.07.680926\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"GNAT1 encodes the α-subunit of rod transducin, a key G-protein in the rod phototransduction cascade; it is activated upon rhodopsin stimulation, amplifies the light signal by activating downstream effectors (including cGMP phosphodiesterase), and terminates signaling via intrinsic GTPase activity in the Switch 2 domain — loss-of-function mutations cause stationary night blindness or progressive rod-cone dystrophy, while constitutively activating GTPase-impaired mutants (e.g., p.Gln200Glu) also cause dominant night blindness by locking the cascade in an active state.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GNAT1 encodes the α-subunit of rod transducin, a heterotrimeric G-protein that couples light-activated rhodopsin to downstream phototransduction effectors in retinal rod photoreceptors. Upon photon absorption by rhodopsin, GNAT1 exchanges GDP for GTP and activates cGMP phosphodiesterase (PDE6), amplifying the visual signal; signal termination depends on intrinsic GTPase activity localized to the Switch 2 domain, and mutations impairing this activity (e.g., p.Gln200Glu) lock the cascade in a constitutively active state [PMID:17584859]. Loss-of-function mutations—including missense (p.Gly38Asp, p.Asp129Gly), truncating, and splice-disrupting variants—abolish rod-mediated signaling, causing autosomal recessive congenital stationary night blindness and, in some cases, progressive rod-cone dystrophy [PMID:19766629, PMID:22190596, PMID:26472407]. Dominant gain-of-function or dominant-negative missense variants (p.Gln200Glu, p.Ile52Asn) cause autosomal dominant Riggs-type congenital stationary night blindness through mechanisms that do not involve gross protein mislocalization [PMID:17584859, PMID:29850563].\",\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined how specific GNAT1 mutations differentially disrupt transducin function: p.Gly38Asp abolishes effector activation while p.Gln200Glu in the Switch 2 GTPase active site impairs GTP hydrolysis, establishing that both loss-of-function and constitutive-activation mechanisms can underlie night blindness.\",\n      \"evidence\": \"In vitro expression assays, trypsin protection assays, and crystal-structure-based modeling of recombinant α-transducin variants\",\n      \"pmids\": [\"17584859\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"GTPase impairment of p.Gln200Glu inferred from trypsin protection and modeling rather than direct GTP hydrolysis rate measurement\",\n        \"No in vivo electrophysiological confirmation of constitutive activation\",\n        \"Structural consequences not validated by direct crystallography of the mutant\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrated that complete loss of rod α-transducin protein, caused by a nonsense mutation from an intronic deletion disrupting splicing, produces rod dysfunction, establishing that GNAT1 is essential for rod photoreceptor signaling in vivo.\",\n      \"evidence\": \"Western blot, immunohistochemistry, quantitative RT-PCR, and genomic/cDNA sequencing in spontaneous IRD1/IRD2 mouse models\",\n      \"pmids\": [\"19766629\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether rod photoreceptors degenerate progressively in this model was not assessed longitudinally\",\n        \"Mechanism by which absence of α-transducin affects photoreceptor survival versus function not separated\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Linked a specific homozygous missense mutation (p.D129G) to autosomal recessive congenital stationary night blindness in humans and established that GNAT1 retinal expression initiates around postnatal day 7, defining its developmental onset.\",\n      \"evidence\": \"Genome-wide linkage analysis, bidirectional sequencing, and quantitative expression profiling in ocular tissues\",\n      \"pmids\": [\"22190596\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional impact of p.D129G on GTP binding or effector activation not directly assayed\",\n        \"Expression timing studied in mouse; human developmental onset not confirmed\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Expanded the clinical spectrum by showing that a homozygous GNAT1 truncating mutation causes not only stationary night blindness but also late-onset progressive rod-cone dystrophy, establishing that complete loss of transducin can lead to photoreceptor degeneration.\",\n      \"evidence\": \"Targeted gene panel sequencing of 182 retinopathy genes with clinical phenotyping including ERG and fundoscopy\",\n      \"pmids\": [\"26472407\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Molecular mechanism linking absence of transducin to progressive photoreceptor degeneration unknown\",\n        \"Single family; broader genotype-phenotype correlation for progressive disease not established\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified a novel dominant GNAT1 missense variant (p.Ile52Asn) in the first α-helix and showed that CSNB-associated mutants do not mislocalize, ruling out gross subcellular redistribution as a dominant disease mechanism.\",\n      \"evidence\": \"Cosegregation analysis, 3D structural modeling, and subcellular localization of overexpressed mutants in mammalian cells\",\n      \"pmids\": [\"29850563\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Localization assay was in overexpressing non-photoreceptor cells without functional rescue—relevance to rod outer segments uncertain\",\n        \"Dominant-negative versus gain-of-function mechanism not distinguished biochemically\",\n        \"No assessment of interaction with rhodopsin or Gβγ subunits\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Using Gnat1/Gnat2 double-knockout mice, demonstrated that complete elimination of rod and cone transducin abolishes classical phototransduction but melanopsin-driven intrinsically photosensitive RGCs can still mediate pattern-forming vision, placing GNAT1 loss in the context of residual non-rod/cone visual function.\",\n      \"evidence\": \"Visual evoked potential and ERG recordings in Gnat1−/−;Gnat2cpfl3/cpfl3 double-knockout mice\",\n      \"pmids\": [\"36605613\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether melanopsin-mediated vision compensates behaviorally in GNAT1-deficient humans not tested\",\n        \"Temporal and contrast sensitivity limits of the residual pathway not fully characterized\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The precise structural and biochemical basis of dominant GNAT1 mutations (e.g., how p.Ile52Asn or p.Gln200Glu disrupt the transducin cycle at atomic resolution) and the mechanism by which complete transducin loss leads to progressive photoreceptor degeneration remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No high-resolution structure of disease-associated GNAT1 mutants\",\n        \"Molecular pathway from transducin absence to rod-cone degeneration not identified\",\n        \"No gene therapy or rescue experiments reported for GNAT1 deficiency\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1, 5]}\n    ],\n    \"localization\": [],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [0, 1, 2, 5]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"complexes\": [\n      \"rod transducin heterotrimer\"\n    ],\n    \"partners\": [\n      \"PDE6\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}